Cargando…

Site-Specific Perturbations of Alpha-Synuclein Fibril Structure by the Parkinson's Disease Associated Mutations A53T and E46K

Parkinson's disease (PD) is pathologically characterized by the presence of Lewy bodies (LBs) in dopaminergic neurons of the substantia nigra. These intracellular inclusions are largely composed of misfolded α-synuclein (AS), a neuronal protein that is abundant in the vertebrate brain. Point mu...

Descripción completa

Detalles Bibliográficos
Autores principales: Lemkau, Luisel R., Comellas, Gemma, Lee, Shin W., Rikardsen, Lars K., Woods, Wendy S., George, Julia M., Rienstra, Chad M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3591419/
https://www.ncbi.nlm.nih.gov/pubmed/23505409
http://dx.doi.org/10.1371/journal.pone.0049750
_version_ 1782262052918657024
author Lemkau, Luisel R.
Comellas, Gemma
Lee, Shin W.
Rikardsen, Lars K.
Woods, Wendy S.
George, Julia M.
Rienstra, Chad M.
author_facet Lemkau, Luisel R.
Comellas, Gemma
Lee, Shin W.
Rikardsen, Lars K.
Woods, Wendy S.
George, Julia M.
Rienstra, Chad M.
author_sort Lemkau, Luisel R.
collection PubMed
description Parkinson's disease (PD) is pathologically characterized by the presence of Lewy bodies (LBs) in dopaminergic neurons of the substantia nigra. These intracellular inclusions are largely composed of misfolded α-synuclein (AS), a neuronal protein that is abundant in the vertebrate brain. Point mutations in AS are associated with rare, early-onset forms of PD, although aggregation of the wild-type (WT) protein is observed in the more common sporadic forms of the disease. Here, we employed multidimensional solid-state NMR experiments to assess A53T and E46K mutant fibrils, in comparison to our recent description of WT AS fibrils. We made de novo chemical shift assignments for the mutants, and used these chemical shifts to empirically determine secondary structures. We observe significant perturbations in secondary structure throughout the fibril core for the E46K fibril, while the A53T fibril exhibits more localized perturbations near the mutation site. Overall, these results demonstrate that the secondary structure of A53T has some small differences from the WT and the secondary structure of E46K has significant differences, which may alter the overall structural arrangement of the fibrils.
format Online
Article
Text
id pubmed-3591419
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-35914192013-03-15 Site-Specific Perturbations of Alpha-Synuclein Fibril Structure by the Parkinson's Disease Associated Mutations A53T and E46K Lemkau, Luisel R. Comellas, Gemma Lee, Shin W. Rikardsen, Lars K. Woods, Wendy S. George, Julia M. Rienstra, Chad M. PLoS One Research Article Parkinson's disease (PD) is pathologically characterized by the presence of Lewy bodies (LBs) in dopaminergic neurons of the substantia nigra. These intracellular inclusions are largely composed of misfolded α-synuclein (AS), a neuronal protein that is abundant in the vertebrate brain. Point mutations in AS are associated with rare, early-onset forms of PD, although aggregation of the wild-type (WT) protein is observed in the more common sporadic forms of the disease. Here, we employed multidimensional solid-state NMR experiments to assess A53T and E46K mutant fibrils, in comparison to our recent description of WT AS fibrils. We made de novo chemical shift assignments for the mutants, and used these chemical shifts to empirically determine secondary structures. We observe significant perturbations in secondary structure throughout the fibril core for the E46K fibril, while the A53T fibril exhibits more localized perturbations near the mutation site. Overall, these results demonstrate that the secondary structure of A53T has some small differences from the WT and the secondary structure of E46K has significant differences, which may alter the overall structural arrangement of the fibrils. Public Library of Science 2013-03-07 /pmc/articles/PMC3591419/ /pubmed/23505409 http://dx.doi.org/10.1371/journal.pone.0049750 Text en © 2013 Lemkau et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Lemkau, Luisel R.
Comellas, Gemma
Lee, Shin W.
Rikardsen, Lars K.
Woods, Wendy S.
George, Julia M.
Rienstra, Chad M.
Site-Specific Perturbations of Alpha-Synuclein Fibril Structure by the Parkinson's Disease Associated Mutations A53T and E46K
title Site-Specific Perturbations of Alpha-Synuclein Fibril Structure by the Parkinson's Disease Associated Mutations A53T and E46K
title_full Site-Specific Perturbations of Alpha-Synuclein Fibril Structure by the Parkinson's Disease Associated Mutations A53T and E46K
title_fullStr Site-Specific Perturbations of Alpha-Synuclein Fibril Structure by the Parkinson's Disease Associated Mutations A53T and E46K
title_full_unstemmed Site-Specific Perturbations of Alpha-Synuclein Fibril Structure by the Parkinson's Disease Associated Mutations A53T and E46K
title_short Site-Specific Perturbations of Alpha-Synuclein Fibril Structure by the Parkinson's Disease Associated Mutations A53T and E46K
title_sort site-specific perturbations of alpha-synuclein fibril structure by the parkinson's disease associated mutations a53t and e46k
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3591419/
https://www.ncbi.nlm.nih.gov/pubmed/23505409
http://dx.doi.org/10.1371/journal.pone.0049750
work_keys_str_mv AT lemkauluiselr sitespecificperturbationsofalphasynucleinfibrilstructurebytheparkinsonsdiseaseassociatedmutationsa53tande46k
AT comellasgemma sitespecificperturbationsofalphasynucleinfibrilstructurebytheparkinsonsdiseaseassociatedmutationsa53tande46k
AT leeshinw sitespecificperturbationsofalphasynucleinfibrilstructurebytheparkinsonsdiseaseassociatedmutationsa53tande46k
AT rikardsenlarsk sitespecificperturbationsofalphasynucleinfibrilstructurebytheparkinsonsdiseaseassociatedmutationsa53tande46k
AT woodswendys sitespecificperturbationsofalphasynucleinfibrilstructurebytheparkinsonsdiseaseassociatedmutationsa53tande46k
AT georgejuliam sitespecificperturbationsofalphasynucleinfibrilstructurebytheparkinsonsdiseaseassociatedmutationsa53tande46k
AT rienstrachadm sitespecificperturbationsofalphasynucleinfibrilstructurebytheparkinsonsdiseaseassociatedmutationsa53tande46k